Skip to main content
. 2004 Apr;239(4):491–500. doi: 10.1097/01.sla.0000118751.95179.c6

graphic file with name 9FF5.jpg

FIGURE 5. The cumulative survival with regard to NF-κB status. The median survivals of those were positive for NF-κB group (n = 59) was 7 months (95% CI, P < 0.05), compared with 12 months (95% CI; P = 0.04) in the NF-κB-negative group (n = 38).